Abstract 8382: Body Mass Index and Thromboembolic, Cardiovascular, and Mortality Outcomes in Patients with Atrial Fibrillation: A Real-World Propensity-Matched Analysis
Abstract
Background: Body mass index (BMI) is strongly associated with cardiovascular outcomes in patients with atrial fibrillation (AF). Although obesity is a recognized risk factor for AF development, emerging evidence suggests the presence of an "obesity paradox," where higher BMI may be associated with improved outcomes after AF diagnosis. However, the relationship between obesity and thromboembolic complications in AF remains incompletely characterized. Hypothesis: Among patients with AF, obesity would be associated with lower hazards of thromboembolic complications despite increased heart failure burden compared with normal BMI. Methods: Using the TriNetX Global Collaborative Network, an international federated health research network spanning up to 171 healthcare organizations, we conducted a retrospective propensity score matched cohort study of adults with AF and BMI ≥30 compared with AF patients with normal BMI (19-24.9) (Figure 1). Cohorts were balanced using 1:1 propensity score matching for demographics, cardiovascular comorbidities, malignancy, smoking status, chronic kidney disease, and anticoagulant therapy. Outcomes included cerebral infarction, transient ischemic attack (TIA), arterial embolism, acute limb ischemia, mesenteric ischemia, heart failure (HF), myocardial infarction (MI), and all-cause mortality. Cox proportional hazards models were used to estimate hazard ratios (HRs) with 95% confidence intervals (CIs). Risk ratios and risk differences were also calculated to characterize the magnitude of association. Results: After propensity score matching, 236,080 patients were included in each cohort. Mean age was 73.6 years, 48.6% were female, 72.4% had hypertension. Mean follow-up ranged from 520 to 769 days across cohorts. Obesity was associated with lower hazards of cerebral infarction (HR 0.891, 95% CI 0.869-0.915; p<0.001), arterial embolism (HR 0.785, 95% CI 0.745-0.828; p<0.001), acute limb ischemia (HR 0.784, 95% CI 0.731-0.841; p<0.001), and mesenteric ischemia (HR 0.669, 95% CI 0.619-0.723; p<0.001). TIA and MI risks were similar between cohorts (HR 0.982, 95% CI 0.948-1.016 and HR 0.984, 95% CI 0.962-1.007, respectively). In contrast, obesity was associated with increased hazards of HF (HR 1.332, 95% CI 1.310-1.355; p<0.001), while all-cause mortality was significantly lower among patients with obesity (HR 0.601, 95% CI 0.595-0.607; p<0.001) (Figure 2). Conclusions: Among patients with AF, obesity was associated with lower hazards of cerebral infarction, arterial embolism, acute limb ischemia, and mesenteric ischemia, despite increased HF risk. All-cause mortality was also significantly lower among patients with obesity. These findings support the presence of an obesity paradox in AF and suggest that patients with normal BMI may represent a subgroup at increased thromboembolic vulnerability warranting closer clinical monitoring.